CG Oncology, Inc. (CGON) Surges 25.0%: Is This an Indication of Further Gains?

CG Oncology, Inc. (CGON) shares ended the last trading session 25% higher at $27.97. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 15.3% loss over the past four weeks.CG Oncology’s shares jumped 25% on Monday after the company unveiled exceptionally durable best-in-disease phase III data for its bladder cancer candidate, cretostimogene grenadenorepvec, at the American Urological Association meeting. In the BOND-0 ...